NYSEARCA:XBI - SPDR S&P Biotech ETF Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $79.52 +1.97 (+2.54 %) (As of 11/18/2018 04:00 PM ET)Previous Close$79.52Today's Range$76.6910 - $80.0752-Week Range$73.97 - $101.55Volume8.37 million shsAverage Volume4.84 million shsMarket CapitalizationN/AP/E RatioN/ADividend Yield0.29%BetaN/A ProfileDiscussionChartDividendInstitutional OwnershipHeadlinesOptions ChainSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor. Receive XBI News and Ratings via Email Sign-up to receive the latest news and ratings for XBI and its competitors with MarketBeat's FREE daily newsletter. Basic Details Issuer SSgA Fund NameSPDR S&P Biotech ETF Tax ClassificationRegulated Investment Company SymbolNYSEARCA:XBI Inception Date1/31/2006 Fund ManagerMichael Feehily, Karl Schneider, Raymond Donofrio Webwww.spdrs.com Phone+1-866-7872257 Fund Focus Asset ClassEquity BenchmarkS&P Biotechnology Select Industry TR USD CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Fund Statistics Assets Under Management$4.50 billion Average Daily Volume$7.94 million Discount/Premium6.22% ETF Expenses Management Fee0.35% Other Expenses0.00% Total Expenses0.35% Fee Waiver0.00% Net Expenses0.35%Administrator, Advisor and Custodian AdministratorSSGA Funds Management, Inc. AdvisorSSgA Funds Management, Inc. CustodianState Street Bank and Trust Company DistributorState Street Global Advisors Funds Distributors, LLC Transfer AgentState Street Bank and Trust Company Trustee Lead Market MakerVirtu Financial SPDR S&P Biotech ETF (NYSEARCA:XBI) Frequently Asked Questions What is SPDR S&P Biotech ETF's stock symbol? SPDR S&P Biotech ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI." How often does SPDR S&P Biotech ETF pay dividends? What is the dividend yield for SPDR S&P Biotech ETF? SPDR S&P Biotech ETF announced a quarterly dividend on Friday, September 21st. Shareholders of record on Monday, September 24th will be given a dividend of $0.0726 per share on Wednesday, September 26th. This represents a $0.29 annualized dividend and a yield of 0.37%. The ex-dividend date is Friday, September 21st. This is a boost from SPDR S&P Biotech ETF's previous quarterly dividend of $0.06. View SPDR S&P Biotech ETF's Dividend History. Has SPDR S&P Biotech ETF been receiving favorable news coverage? Media stories about XBI stock have been trending neutral on Sunday, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. SPDR S&P Biotech ETF earned a daily sentiment score of 0.2 on InfoTrie's scale. They also assigned media stories about the exchange traded fund a news buzz of 9.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next few days. Who are SPDR S&P Biotech ETF's key executives? SPDR S&P Biotech ETF's management team includes the folowing people: James E. Ross, President, Trustee (Age 52)Peter A. Ambrosini, Chief Compliance Officer (Age 69)Michael P. Riley, Vice President (Age 44)Gary L. French, Treasurer (Age 64)John W. Clark, Assistant Treasurer (Age 46)Matthew W. Flaherty, Assistant Treasurer (Age 42)Chad C. Hallett, Assistant Treasurer of Street tracks series trust (Age 47)Mary Moran Zeven, Secretary (Age 52)Scott M. Zoltowski, Assistant Secretary (Age 44)Dave Kelly, Independent Trustee Who are SPDR S&P Biotech ETF's major shareholders? SPDR S&P Biotech ETF's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include JPMorgan Chase & Co. (5.74%), Wells Fargo & Company MN (2.92%), Rafferty Asset Management LLC (1.68%), Assetmark Inc. (1.49%), Alliancebernstein L.P. (1.44%) and SG Americas Securities LLC (0.99%). Which institutional investors are selling SPDR S&P Biotech ETF stock? XBI stock was sold by a variety of institutional investors in the last quarter, including Assetmark Inc., SG Americas Securities LLC, Alliancebernstein L.P., Tekla Capital Management LLC, QVT Financial LP, Beaumont Financial Partners LLC, Thrivent Financial for Lutherans and CIBC World Markets Inc.. Which institutional investors are buying SPDR S&P Biotech ETF stock? XBI stock was bought by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Rafferty Asset Management LLC, Migdal Insurance & Financial Holdings Ltd., Harel Insurance Investments & Financial Services Ltd., Wells Fargo & Company MN, Hsbc Holdings PLC, McGuire Investment Group LLC and LPL Financial LLC. How do I buy shares of SPDR S&P Biotech ETF? Shares of XBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is SPDR S&P Biotech ETF's stock price today? One share of XBI stock can currently be purchased for approximately $79.52. What is SPDR S&P Biotech ETF's official website? The official website for SPDR S&P Biotech ETF is https://www.spdrs.com/. How can I contact SPDR S&P Biotech ETF? SPDR S&P Biotech ETF's mailing address is One Lincoln Street, Boston, 02111, United States. The exchange traded fund can be reached via phone at +1-866-7872257. MarketBeat Community Rating for SPDR S&P Biotech ETF (NYSEARCA XBI)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 58 (Vote Outperform)Underperform Votes: 77 (Vote Underperform)Total Votes: 135MarketBeat's community ratings are surveys of what our community members think about SPDR S&P Biotech ETF and other stocks. Vote "Outperform" if you believe XBI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XBI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/18/2018 by MarketBeat.com StaffFeatured Article: What is systematic risk?